1Roviello F, Marrelli D, Morgagni P, et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes:a longitudinal multicenter study [J]. Ann Surg Oncol, 2002,9 ( 9 ) : 894-900.
2Bruno L, Nesi G, Montinaro F, et al. Clinicopathologic characteristics and outcome dicators in node-negative gastric eancer[J].J Surg On- col, 2000,74(1) : 30-32.
3Wu CW,Hsieh MC,Lo SS,et al. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adeno- carcinoma[J]. Gut, 1996,38(4):525-527.
4Bouvier AM,Haas O,Piard F,et al. How many nodes must be exam- ined to accurately stage gastric carcinomas? Results from a popula- tion based study[J]. Cancer,2002,94( 11 ):2862-2866.
5Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1038 patients [J]. Ann Surg, 2000,232( 3 ) : 362-371.
6Giuliani A, Caporale A, Corona M, et al. Lymphadenectomy in gastric cancer:influence on prognosis of lymph node count [J]. J Exp Clin Cancer Res, 2004,23 ( 2 ) : 215-224.
7Zilberstein B,da Costa Martins B,Jacob CE,et al. Complications of gastrectomy with lymphadeneetomy in gastric cancer [J]. Gastric Cancer, 2004,7(4) : 254-259.
4Nakamura K,Ozaki N,Yamada T,et al.Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer[J].Surgery,2005,137(5):511.
5Sobin LH,Wittekind CH.TNM classification of malignant tumors[M].International Union Against Cancer (UICC).5th edition.New York:John Wiley & Sons,inc.,1997:59~62.
6Sakuramoto S,Sasako M,Yamaguchi T,et al.Adjuvant ch-emotherapy for gastric cancer with S-1,an oral fluoropyrimidine[J].N Engl J Med,2007,357(18):1810.
7P Sun,J Xiang,Z Chen,et al.Meta-analysis of adjuvant c-hemotherapy after radical surgery for advanced gastric cancer[J].Br J Surg,2009,96(1):26.
8Rivera F,Galán M,Tabernero J,et al.PhaseⅡtrial of preoperative irinotecancisplatin followed by concurrent irinotecancisplatin and radio-therapy for respectable locally advanced gastric and esophagogastric junction adenocarcinoma[J].Int J Radiat Oncol Biol Phys,2009,75(5):1430.
9Stahl M,Walz MK,Stuschke M,et al.Phase Ⅲ comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction[J].J Clin Oncol,2009,27(6):851.
